BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 24508914)

  • 1. Novel insights into G protein and G protein-coupled receptor signaling in cancer.
    O'Hayre M; Degese MS; Gutkind JS
    Curr Opin Cell Biol; 2014 Apr; 27():126-35. PubMed ID: 24508914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled receptors as promising cancer targets.
    Liu Y; An S; Ward R; Yang Y; Guo XX; Li W; Xu TR
    Cancer Lett; 2016 Jul; 376(2):226-39. PubMed ID: 27000991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
    Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q
    Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Akt/protein kinase B by G protein-coupled receptors. A role for alpha and beta gamma subunits of heterotrimeric G proteins acting through phosphatidylinositol-3-OH kinasegamma.
    Murga C; Laguinge L; Wetzker R; Cuadrado A; Gutkind JS
    J Biol Chem; 1998 Jul; 273(30):19080-5. PubMed ID: 9668091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Insight into GPCR and G-Proteins as Cancer Drivers.
    Chaudhary PK; Kim S
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular transglutaminase 2 induces myotube hypertrophy through G protein-coupled receptor 56.
    Kitakaze T; Yoshikawa M; Kobayashi Y; Kimura N; Goshima N; Ishikawa T; Ogata Y; Yamashita Y; Ashida H; Harada N; Yamaji R
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118563. PubMed ID: 31666191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Ras and Rho GTPases and MAP Kinases by G-protein-coupled receptors.
    Chiariello M; Vaqué JP; Crespo P; Gutkind JS
    Methods Mol Biol; 2010; 661():137-50. PubMed ID: 20811981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WIF1 can effectively co-regulate pro-apoptotic activity through the combination with DKK1.
    Ko YB; Kim BR; Yoon K; Choi EK; Seo SH; Lee Y; Lee MA; Yang JB; Park MS; Rho SB
    Cell Signal; 2014 Nov; 26(11):2562-72. PubMed ID: 25086206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKB/Akt-dependent regulation of cell motility.
    Xue G; Hemmings BA
    J Natl Cancer Inst; 2013 Mar; 105(6):393-404. PubMed ID: 23355761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B.
    Montaner S; Sodhi A; Pece S; Mesri EA; Gutkind JS
    Cancer Res; 2001 Mar; 61(6):2641-8. PubMed ID: 11289142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transduction pathways of G protein-coupled receptors and their cross-talk with receptor tyrosine kinases: lessons from bradykinin signaling.
    Liebmann C; Böhmer FD
    Curr Med Chem; 2000 Sep; 7(9):911-43. PubMed ID: 10911023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G protein-coupled receptors (GPCRs) That Signal via Protein Kinase A (PKA) Cross-talk at Insulin Receptor Substrate 1 (IRS1) to Activate the phosphatidylinositol 3-kinase (PI3K)/AKT Pathway.
    Law NC; White MF; Hunzicker-Dunn ME
    J Biol Chem; 2016 Dec; 291(53):27160-27169. PubMed ID: 27856640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer.
    Brechbiel J; Miller-Moslin K; Adjei AA
    Cancer Treat Rev; 2014 Jul; 40(6):750-9. PubMed ID: 24613036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase.
    Hsiung SC; Adlersberg M; Arango V; Mann JJ; Tamir H; Liu KP
    J Neurochem; 2003 Oct; 87(1):182-94. PubMed ID: 12969265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer.
    Lien EC; Lyssiotis CA; Cantley LC
    Recent Results Cancer Res; 2016; 207():39-72. PubMed ID: 27557534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling.
    Ambesi A; McKeown-Longo PJ
    Mol Cancer Res; 2009 Feb; 7(2):255-65. PubMed ID: 19208746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endosomal sorting complex required for transport pathway mediates chemokine receptor CXCR4-promoted lysosomal degradation of the mammalian target of rapamycin antagonist DEPTOR.
    Verma R; Marchese A
    J Biol Chem; 2015 Mar; 290(11):6810-24. PubMed ID: 25605718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling by integrin receptors.
    Kumar CC
    Oncogene; 1998 Sep; 17(11 Reviews):1365-73. PubMed ID: 9779984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.